March 2020

ONCOLOGY

EVOLVING CANCER CARE DURING COVID-19

Featuring: Leonidas C. Platanias, MD, PhD

Episode Summary

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has rapidly evolved to develop new protocols and a Coronavirus Disease 2019 (COVID-19) response team to ensure the safe and effective treatment for cancer patients during the COVID-19 pandemic. In this episode, Leonidas C. Platanias, MD, PhD, director of the Lurie Cancer Center of Northwestern University, explains the protocols in place to minimize risk, and how the team is safely delivering critical treatment and providing emotional support for patients during this time.
Leonidas C. Platanias, MD, PhD, is the director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Jesse, Sara, Andrew, Abigail, Benjamin and Elizabeth Lurie Professor of Oncology. Platanias' research work focuses on cytokine signaling pathways in malignant cells and the targeting of such pathways for the treatment of leukemia. He has published more than 320 papers and his research has been continuously funded by the NCI for more than 25 years.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like